Key terms

About WVE

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
     
52-week range
     
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date

Key terms

Smart score

Latest WVE news

May 02 3:20am ET Wave Life Sciences’ WVE-006 Advancements: A Buy Rating on Gene Editing Innovations and Strategic Partnerships by TipRanks May 02 2:18am ET Buy Rating Affirmed: Wave Life Sciences’s Promising Future with Clinical Milestones and Strategic GSK Partnership by TipRanks Apr 30 8:50am ET Wave Life announces approval of first CTA for RestorAAtion-2 trial by TipRanks Apr 26 2:16am ET Buy Rating Affirmed: Strategic Partnerships and Clinical Milestones Propel Wave Life Sciences’ Growth Potential by TipRanks Apr 26 2:11am ET Wave Life Sciences: A Promising Buy Rating Based on Strategic GSK Collaboration and Innovative siRNA Platform by TipRanks Apr 23 8:34am ET Wave Life Sciences announces continued momentum in GSK collaboration by TipRanks Apr 23 4:55am ET Wave Life Sciences management to meet virtually with Truist by TipRanks Apr 22 1:44pm ET Wave Life Sciences management to meet virtually with Truist by TipRanks Apr 01 7:21am ET Analysts’ Top Healthcare Picks: Wave Life Sciences (WVE), Passage Bio (PASG) by TipRanks Apr 01 7:21am ET Truist Financial Reaffirms Their Buy Rating on Wave Life Sciences (WVE) by TipRanks Mar 12 6:41am ET Wave Life Sciences price target raised to $19 from $10 at Mizuho by TipRanks Mar 11 2:40am ET Analysts’ Opinions Are Mixed on These Healthcare Stocks: Illumina (ILMN), MoonLake Immunotherapeutics (MLTX) and Wave Life Sciences (WVE) by TipRanks Mar 11 1:10am ET Analysts Are Bullish on These Healthcare Stocks: Wave Life Sciences (WVE), Dexcom (DXCM) by TipRanks Mar 07 9:31am ET Analysts Offer Insights on Healthcare Companies: Iovance Biotherapeutics (IOVA), Brainsway (BWAY) and Wave Life Sciences (WVE) by TipRanks Mar 07 6:06am ET Wave Life Sciences price target raised to $15 from $8 at H.C. Wainwright by TipRanks Mar 06 7:52am ET Wave Life Sciences Unveils New Corporate Presentation by TipRanks Mar 06 7:33am ET Wave Life Sciences reports Q4 EPS (15c), consensus (23c) by TipRanks Feb 27 8:49am ET Wave Life Sciences announces upcoming presentations at MDA conference by TipRanks Feb 02 11:07am ET Biotech Alert: Searches spiking for these stocks today by TipRanks

No recent press releases are available for WVE

WVE Financials

1-year income & revenue

Key terms

WVE Forecasts

analyst rating

  • buy
  • hold
  • sell

We're sorry, but this
information is
temporarily unavailable.

1-year stock price forecast

WVE Competitors

$ Market cap P/E ratio $ Price 1d change 52-week range

Key terms

Latest investing news

People walk by the New York Stock Exchange (NYSE) on March 20, 2024 in New York City. The Dow was up slightly in late morning trading as traders analyze the Federal Reserve's latest decision on interest rates.
Spencer Platt/Getty Images
Stocks close higher after softer-than-expected jobs report fuels hopes of an earlier rate cut
People work at a Starbucks in Manhattan on February 02, 2024 in New York City.
Spencer Platt/Getty Images
Restaurants are competing for frugal diners’ dollars
Traders work on the floor of the New York Stock Exchange during afternoon trading on April 09, 2024 in New York City.
Michael M. Santiago/Getty Images/File
Sell in May and go away? Think again
The Marriner S. Eccles Federal Reserve building in Washington, DC, on Thursday, Dec. 28, 2023.
Valerie Plesch/Bloomberg/Getty Images
The Fed announced a big change today. And no, we’re not talking about interest rates